Wall Street closed the first full week of 2026 looking less like a Santa rally and more like a New Year’s rebalancing, as investors rotated briskly beneath mostly resilient headline indexes. The Dow (+2.3%) and small-cap Russell 2000 (+4.6%) outperformed, helped by…
US stocks finished Thursday with a split personality: the Dow marched confidently higher, small caps finally stole a headline, and Big Tech discovered that gravity still works, even in an AI bull market.
Major indexes
The Dow Jones Industrial Average added about 270 points, or .55%,…
The major U.S. equity benchmarks spent Wednesday doing their best impression of a tightrope act, wobbling on tariff angst and rate jitters but largely maintaining their lofty perch near record territory.
Indexes: Gravity Check, Not Freefall
The S&P 500 edged lower, slipping…
Wall Street closed Tuesday with a spring in its step and a raised eyebrow, as blue chips powered to fresh records while small caps joined the party. A looming Supreme Court ruling on President Trump’s tariffs, another shutdown deadline, and a packed…
GeoVax Labs (NASDAQ: GOVX) is heading into the 44th Annual J.P. Morgan Healthcare Conference week ("JPM2026") in San Francisco, CA Jan. 12-15 with the kind of narrative biotech investors typically like to hear: a differentiated platform, large funded trials lining up, and…
AMD’s latest CES turn on the Las Vegas strip reads less like a product briefing and more like a full‑throated bid to turn “AI everywhere” from slogan into market share, from the data center rack down to the ultraportable on your lap.…
As the opening week of 2026 trading gathers steam, investors seem content to embrace risk—so long as the Fed stays predictable, Congress keeps the lights on, and oil, gold and bitcoin provide just enough drama to keep everyone awake at the morning…
All told, the first, abbreviated week of 2026 felt less like the start of a new market regime and more like a terse sequel: the same cast of AI heroes, EV skeptics, tariff subplots and Fed suspense, just with a new calendar…
U.S. stocks wrapped 2025 with a modest pullback on Wednesday, as traders balanced a euphoric year in risk assets against the sobering reality of lofty valuations, rich precious metals, and a Federal Reserve that now cuts rates with all the enthusiasm of…
In a fitting coda to 2025, Tuesday’s market looked less like a grand finale and more like a dress rehearsal for 2026: stocks near records, AI titans and GLP‑1 champions still commanding the marquee, and a supporting cast of tariffs, deficits, metals…
